Innovation of the week: Serenity now
Serenity may be a few smartphone taps away
Serenity may be a few smartphone taps away, said Heather Somerville in the San Jose Mercury News. Thync, a Bluetooth-connected device that attaches to the forehead, purports to deliver a "mood-altering fix" by stimulating nerves near the brain with electricity. Using a linked smartphone app, wearers can choose to receive either "calm vibes" or "energy vibes."
Thync's inventors, a Silicon Valley veteran and a neuroscience expert, say their goal is to provide "an alternative to alcohol or Red Bull" for busy professionals looking "to wind down or rev up." The device has been rigorously tested. Over the past year and a half, the company has conducted placebo-controlled studies of Thync on some 3,500 people and seen "changes in users' temperature, body chemistry, and facial expression" as their brains were stimulated. The device starts at $299.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
Today's political cartoons - May 4, 2024
Cartoons Saturday's cartoons - reflections in the pond, riding shotgun, and more
By The Week US Published
-
5 high-caliber cartoons about Kristi Noem shooting her puppy
Cartoons Artists take on the rainbow bridge, a farm upstate, and more
By The Week US Published
-
The Week Unwrapped: Why is the world running low on blood?
Podcast Scientists believe universal donor blood is within reach – plus, the row over an immersive D-Day simulation, and an Ozempic faux pas
By The Week Staff Published